Cargando…
Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement
In August 2020, pharmacists were authorized to prescribe contraceptives in Minnesota outside of a collaborative practice agreement. To practice under this new authorization, pharmacists must complete formal contraceptive prescribing training and follow guidelines which include restrictions on patien...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
University of Minnesota Libraries Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119991/ https://www.ncbi.nlm.nih.gov/pubmed/35601594 http://dx.doi.org/10.24926/iip.v12i3.3923 |
_version_ | 1784710806579970048 |
---|---|
author | Facciolo, Federico Farley, Joel |
author_facet | Facciolo, Federico Farley, Joel |
author_sort | Facciolo, Federico |
collection | PubMed |
description | In August 2020, pharmacists were authorized to prescribe contraceptives in Minnesota outside of a collaborative practice agreement. To practice under this new authorization, pharmacists must complete formal contraceptive prescribing training and follow guidelines which include restrictions on patient’s age and appropriate screening and assessment requirements. Allowing pharmacists to prescribe contraceptives has the potential to extend contraceptive access, decrease overall health care costs, and improve outcomes. However, barriers to the expansion of contraceptive prescribing by pharmacists may prevent widespread adoption of this practice in Minnesota. A key concern among pharmacists is a lack of reimbursement for providing this service. Other states adopting contraceptive prescribing by pharmacists which have not paid for this service have reported limited implementation and discontinuation of this service. To improve contraceptive access to Minnesotans, policymakers should consider expanding provider status to pharmacists and providing reimbursement to pharmacists for contraceptive services. |
format | Online Article Text |
id | pubmed-9119991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | University of Minnesota Libraries Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-91199912022-05-20 Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement Facciolo, Federico Farley, Joel Innov Pharm Commentary In August 2020, pharmacists were authorized to prescribe contraceptives in Minnesota outside of a collaborative practice agreement. To practice under this new authorization, pharmacists must complete formal contraceptive prescribing training and follow guidelines which include restrictions on patient’s age and appropriate screening and assessment requirements. Allowing pharmacists to prescribe contraceptives has the potential to extend contraceptive access, decrease overall health care costs, and improve outcomes. However, barriers to the expansion of contraceptive prescribing by pharmacists may prevent widespread adoption of this practice in Minnesota. A key concern among pharmacists is a lack of reimbursement for providing this service. Other states adopting contraceptive prescribing by pharmacists which have not paid for this service have reported limited implementation and discontinuation of this service. To improve contraceptive access to Minnesotans, policymakers should consider expanding provider status to pharmacists and providing reimbursement to pharmacists for contraceptive services. University of Minnesota Libraries Publishing 2021-06-10 /pmc/articles/PMC9119991/ /pubmed/35601594 http://dx.doi.org/10.24926/iip.v12i3.3923 Text en © Individual authors https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License, which permits noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commentary Facciolo, Federico Farley, Joel Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement |
title | Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement |
title_full | Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement |
title_fullStr | Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement |
title_full_unstemmed | Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement |
title_short | Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for Improvement |
title_sort | minnesota policy on pharmacist-prescribed contraceptives: benefits, limitations, and opportunities for improvement |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119991/ https://www.ncbi.nlm.nih.gov/pubmed/35601594 http://dx.doi.org/10.24926/iip.v12i3.3923 |
work_keys_str_mv | AT facciolofederico minnesotapolicyonpharmacistprescribedcontraceptivesbenefitslimitationsandopportunitiesforimprovement AT farleyjoel minnesotapolicyonpharmacistprescribedcontraceptivesbenefitslimitationsandopportunitiesforimprovement |